Home Featured Page 162

Featured

Latest

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Q3’25 Investor Survey: What are Investors Most Concerned About?

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research Agenda

Psychedelic Insights Playground

Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright &...

TRYP THERAPEUTICS INC. ANNOUNCES BOARD CHANGES AND CLOSING OF FIRST TRANCHE...

Psyence Group Corporate Update

Silo Pharma Expands License Agreement and Patent Portfolio

Core One Labs’ Upgrades to OTCQB Venture Market

Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment...

Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to...

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million...

PT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women,...

Stephen Bardin to Join atai Life Sciences as CFO Designate

1...161162163...300 Page 162 of 300

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores...

Q3’25 Investor Survey: What are Investors Most Concerned About?

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Q3’25 Investor Survey: What are Investors Most Concerned About?

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research Agenda

Psychedelic Insights Playground

Brad Adams PhD – LAMPS

Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright &...

TRYP THERAPEUTICS INC. ANNOUNCES BOARD CHANGES AND CLOSING OF FIRST TRANCHE...

Psyence Group Corporate Update

Silo Pharma Expands License Agreement and Patent Portfolio

Core One Labs’ Upgrades to OTCQB Venture Market

Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment...

Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to...

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million...

PT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women,...

Stephen Bardin to Join atai Life Sciences as CFO Designate

EDITOR PICKS

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores...

Q3’25 Investor Survey: What are Investors Most Concerned About?

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY